Low-density lipoprotein cholesterol and the risk of dementia with stroke

JAMA

Volumn 282, Issue 3, 1999, Pages 254-260

  Moroney, Joan T ^a,c   Tang, Ming Xin ^a,b   Berglund, Lars ^b   Small, Scott ^a,c   Merchant, Carole ^a,c   Bell, Karen ^a,c   Stern, Yaakov ^a,b,c   Mayeux, Richard ^a,b,c  

^a and Epidemiology   (United States)

^b Columbia University ^*  (United States)

^c New York State Psychiatric Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN;

AGED; ALZHEIMER DISEASE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIINFARCT DEMENTIA; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; STROKE;

EID: 0033591928     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.282.3.254     Document Type: Article

References (40)

1. Jorm AF, Jolley D. The incidence of dementia: a meta-analysis. Neurology. 1998;51:728-733.
2. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and the dinical expression of Alzheimer disease: the Nun Study. JAMA. 1997;277:813-817.
3. Slooter AJC, Tang M-X, van Duijn CM, et al. Apolipoprotein E-ε4 and the risk of dementia with stroke. JAMA. 1997;277:818-821.
4. Pablo-Mendez A, Mayeux R, Ngai C, Shea S, Berglund L. Association of Apo E polymorphism with plasma lipid levels in a multiethnic elderly population. Arterioscler Thromb Vasc Biol. 1997;17:3534-3541.
5. Tang M-X, Stern Y, Marder K, et al. The APOE-ε4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics. JAMA. 1998; 279:751-755.
6. Stern Y, Andrews H, Pittman J, et al. Diagnosis of dementia in a heterogeneous population, I: development of a neuropsychological paradigm and quantified correction for education. Arch Neurol. 1992;49: 453-460.
7. Census of Population and Housing: Summary Tape File 1, Technical Documentation [computer diskette]. Washington, DC: Bureau of the Census; 1991.
8. Hatano S. Experience from a multicenter stroke register: a preliminary report. Bull World Health Organ. 1976;54:541-553.
9. Sacco RL, Hauser WA, Mohr JP. Hospitalized stroke in blacks and Hispanics in northern Manhattan. Stroke. 1991;22:1491-1496.
10. Sacco RL, Shi T, Zamanillo MC, Kargman DE. Predictors of mortality and recurrence after hospitalized cerebral infarction in an urban community: the Northern Manhattan Stroke Study. Neurology. 1994;44:626-634.
11. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised. Washington, DC: American Psychiatric Association; 1987.
12. Tatemichi TK, Desmond DW, Mayeux R, et al. Dementia after stroke: baseline frequency, risks, and clinical features in a hospitalized cohort. Neurology. 1992; 42:1185-1193.
13. Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies: report of the NINDS-AIREN International Workshop. Neurology. 1993;43:250-260.
14. McKhann G, Drachman DA, Folstein F, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939-944.
15. Lopes-Virella MF, Stone P, Ellis S, Colwell JA. Cholesterol determination in high-density lipoproteins separated by three different methods. Clin Chem. 1977; 23:882-884.
16. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
17. Tuck CH, Holleran S, Berglund L. Hormonal regulation of lipoprotein(a) levels: effects of estrogen replacement therapy on lipoprotein(a) and acute phase reactants in postmenopausal women. Arterioscler Thromb Vasc Biol. 1997;17:1822-1829.
18. Nauck M, Winkler K, Marz W, Wieland H. Quantitative determination of high-, low-, and very-low-density lipoproteins and lipoprotein(a) by agarose gel electrophoresis and enzymatic cholesterol staining. Clin Chem. 1995;41:1761-1767.
19. Hixson J, Vernier D. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhAI. J Lipid Res. 1991;31:545-548.
20. Korn EL, Graubard BI, Midthune D. Time-to-event analysis of longitudinal follow-up of a survey: choice of the time scale. Am J Epidemiol. 1997;145: 72-80.
21. Mendez I, Hachinski V, Wolfe B. Serum lipids after stroke. Neurology. 1987;37:507-511.
22. Kargman DE, Tuck C, Berglund L, et al. Lipid and lipoprotein levels remain stable in acute ischemic stroke: the Northern Manhattan Stroke Study. Atherosclerosis. 1998;139:391-399.
23. Katzman R, Aronson M, Fuld P, et al. Development of dementing illnesses in an 80-year-old cohort. Ann Neurol. 1989;25:317-324.
24. Kalmijn S, Feskens EJM, Launer LJ, Kromhout D. Cerebrovascular disease, the apolipoprotein E-ε4 allele, and cognitive decline in a community-based study of elderly men. Stroke. 1996;27:2230-2235.
25. Kalmijn S, Launer LJ, Ott A, Witteman J, Hofman A, Breteler MMB. Dietary fat intake and the risk of incident dementia in the Rotterdam study. Ann Neurol. 1997;42:776-782.
26. Kalmijn S, Feskens EJM, Launer LJ, Kromhout D. Polysaturated fatty acids, antioxidants, and cognitive function in very old men. Am J Epidemiol. 1997;145: 33-41.
27. Zimetbaum P, Frishman WH, Ooi WL, et al. Plasma lipids and lipoproteins and the incidence of cardiovascular disease in the very elderly, the Bronx Aging Study. Arterioscler Thromb Vasc Biol. 1992;12:416-423.
28. Yoshitake T, Kiyohara Y, Kato I, et al. Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama Study. Neurology. 1995;45:1161-1168.
29. Carleton RA, Dwyer J, Finberg L, et al. Report of the expert panel on population strategies for blood cholesterol reduction: a statement from the National Cholesterol Education Program, National Heart, Lung, and Blood Institute, National Institutes of Health. Circulation. 1991;839:2154-2232.
30. Sharrett AR, Patsch W, Sorlie PD, Heiss G, Bond MG, Davis CE, for the ARIC Investigators. Associations of lipoproteins cholesterols, apolipoproteins A-1 and B, and triglycerides with carotid atherosclerosis and coronary heart disease: the Atherosclerosis Risk in Communities Study. Arterioscler Thromb Vasc Biol. 1994;14:1098-1104.
31. Breteler MMB, Claus JJ, Grobbee DE, Hofman A. Cardiovascular disease and distribution of cognitive function in elderly people: the Rotterdam Study. BMJ. 1994;308:1604-1608.
32. Tatemichi TK, Desmond DW, Prohovnik I, Eidelberg D. Dementia associated with bilateral carotid occlusions: neuropsychological and haemodynamic course after extracranial to intracranial bypass surgery. J Neurol Neurosurg Psychiatry. 1995;58:633-636.
33. Pedro-Botet J, Senti M, Nogues X, et al. Lipoprotein and apolipoprotein profile in men with ischemic stroke: role of lipoprotein(a), triglyceride-rich lipoproteins, and apolipoprotein E polymorphism. Stroke. 1992;23:1556-1562.
34. Fujiwara Y, Nishihara H, Nakakoshi T, Hasegawa T, Tagami S, Kawakami Y. Elevation of plasma lipid peroxides in non-insulin dependent diabetics with multiple lacunar infarcts. J Atheroscler Thromb. 1997;4: 90-95.
35. Tomlinson BE, Blessed G, Roth M. Observations on the brains of demented old people. J Neurol Sci. 1970;11:205-242.
36. Tatemichi TK, Desmond DW, Prohovnik I, et al. Confusion and memory loss from capsular genu infarction: a thalamocortical disconnection syndrome. Neurology. 1992;42:1966-1979.
37. Cutler RG. Human longevity and aging: possible role of reactive oxygen species. Ann N Y Acad Sci. 1991;621:1-28.
38. Streit WJ, Sparks DL. Activation of microglia in the brains of humans with heart disease and hypercholesterolemic rabbits. J Mol Med. 1997;75:130-138.
39. Sparks DL, Scheff SW, Hunsaker JC, Liu H, Landers T, Gross DR. Induction of Alzheimer-like beta-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol. Exp Neurol. 1994;126:88-94.
40. Bruce-Keller AJ, Umberger G, McFall R, Mattson MP. Food restriction reduces brain damage and improves behavioral outcome following excitotoxic and metabolic insults. Ann Neurol. 1999;45:8-15.